JP2024150751A5 - - Google Patents

Download PDF

Info

Publication number
JP2024150751A5
JP2024150751A5 JP2024127900A JP2024127900A JP2024150751A5 JP 2024150751 A5 JP2024150751 A5 JP 2024150751A5 JP 2024127900 A JP2024127900 A JP 2024127900A JP 2024127900 A JP2024127900 A JP 2024127900A JP 2024150751 A5 JP2024150751 A5 JP 2024150751A5
Authority
JP
Japan
Prior art keywords
antibody
seq
sequence
tslp
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024127900A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024150751A (ja
Filing date
Publication date
Priority claimed from JP2019555854A external-priority patent/JP7330896B2/ja
Application filed filed Critical
Publication of JP2024150751A publication Critical patent/JP2024150751A/ja
Publication of JP2024150751A5 publication Critical patent/JP2024150751A5/ja
Priority to JP2025147176A priority Critical patent/JP2025170430A/ja
Pending legal-status Critical Current

Links

JP2024127900A 2017-04-12 2024-08-02 抗ｔｓｌｐ抗体による喘息治療 Pending JP2024150751A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025147176A JP2025170430A (ja) 2017-04-12 2025-09-04 抗ｔｓｌｐ抗体による喘息治療

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762484864P 2017-04-12 2017-04-12
US62/484,864 2017-04-12
US201762553477P 2017-09-01 2017-09-01
US201762553575P 2017-09-01 2017-09-01
US62/553,477 2017-09-01
US62/553,575 2017-09-01
JP2019555854A JP7330896B2 (ja) 2017-04-12 2018-04-12 抗ｔｓｌｐ抗体による喘息治療
JP2023080295A JP2023099233A (ja) 2017-04-12 2023-05-15 抗ｔｓｌｐ抗体による喘息治療

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023080295A Division JP2023099233A (ja) 2017-04-12 2023-05-15 抗ｔｓｌｐ抗体による喘息治療

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025147176A Division JP2025170430A (ja) 2017-04-12 2025-09-04 抗ｔｓｌｐ抗体による喘息治療

Publications (2)

Publication Number Publication Date
JP2024150751A JP2024150751A (ja) 2024-10-23
JP2024150751A5 true JP2024150751A5 (https=) 2025-04-28

Family

ID=62092313

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019555854A Active JP7330896B2 (ja) 2017-04-12 2018-04-12 抗ｔｓｌｐ抗体による喘息治療
JP2023080295A Withdrawn JP2023099233A (ja) 2017-04-12 2023-05-15 抗ｔｓｌｐ抗体による喘息治療
JP2024127900A Pending JP2024150751A (ja) 2017-04-12 2024-08-02 抗ｔｓｌｐ抗体による喘息治療
JP2025147176A Pending JP2025170430A (ja) 2017-04-12 2025-09-04 抗ｔｓｌｐ抗体による喘息治療

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019555854A Active JP7330896B2 (ja) 2017-04-12 2018-04-12 抗ｔｓｌｐ抗体による喘息治療
JP2023080295A Withdrawn JP2023099233A (ja) 2017-04-12 2023-05-15 抗ｔｓｌｐ抗体による喘息治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025147176A Pending JP2025170430A (ja) 2017-04-12 2025-09-04 抗ｔｓｌｐ抗体による喘息治療

Country Status (22)

Country Link
US (3) US10828365B2 (https=)
EP (1) EP3609917A1 (https=)
JP (4) JP7330896B2 (https=)
KR (2) KR102666879B1 (https=)
CN (1) CN110573525A (https=)
AU (2) AU2018253118B2 (https=)
BR (1) BR112019021482A2 (https=)
CA (1) CA3059364A1 (https=)
CL (1) CL2019002897A1 (https=)
CO (1) CO2019011462A2 (https=)
IL (1) IL269791B (https=)
JO (1) JOP20190243B1 (https=)
MX (1) MX2019012158A (https=)
MY (1) MY207509A (https=)
PE (1) PE20200484A1 (https=)
PH (1) PH12019502331A1 (https=)
SG (1) SG11201909322VA (https=)
TN (1) TN2019000289A1 (https=)
TW (2) TW202523688A (https=)
UA (1) UA130334C2 (https=)
UY (1) UY37676A (https=)
WO (1) WO2018191479A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20210650T1 (hr) * 2015-09-09 2021-05-28 Novartis Ag Protutijela koja vežu timusni stromalni limfopoetin (tslp) i postupci uporabe protutijela
KR102666879B1 (ko) * 2017-04-12 2024-05-23 암젠 인크 항-tslp 항체를 이용한 천식의 치료
JP7628966B2 (ja) 2019-06-04 2025-02-12 ジエンス ヘンルイ メデイシンカンパニー リミテッド 胸線間質性リンパ球増殖因子に結合可能な抗体およびその使用
CA3147044A1 (en) * 2019-07-11 2021-01-14 Tavotek Biotherapeutics (Hong Kong) Limited Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling
EP4025602A4 (en) * 2019-09-04 2023-12-13 Biosion, Inc. TSLP BINDING ANTIBODIES AND USES THEREOF
PH12022551022A1 (en) * 2019-10-28 2023-03-06 Medimmune Ltd Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof
CN114887053B (zh) * 2019-11-29 2026-04-24 康诺亚生物医药科技（成都）有限公司 一种tslp相关病症治疗剂的开发和应用
AU2020400221A1 (en) * 2019-12-13 2022-05-19 Harbour Biomed (Shanghai) Co., Ltd. Anti-TSLP antibody and uses thereof
TW202140550A (zh) 2020-01-29 2021-11-01 瑞士商諾華公司 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
EP4103605A1 (en) * 2020-02-13 2022-12-21 Amgen Inc. Treatment of atopic dermatitis with anti-tslp antibody
MX2022010012A (es) * 2020-02-13 2022-09-07 Amgen Inc Formulaciones de anticuerpos anti-tslp humanos y métodos de tratamiento de una enfermedad inflamatoria.
IL295511A (en) * 2020-02-18 2022-10-01 Amgen Inc Formulations of human anti-tslp antibodies and methods of using them
CN113388035B (zh) * 2020-03-13 2026-02-27 迈威(上海)生物科技股份有限公司 特异性针对人tslp的抗体及其应用
WO2022117079A1 (zh) * 2020-12-03 2022-06-09 江苏恒瑞医药股份有限公司 结合胸腺基质淋巴细胞生成素的抗体及其应用
CN113501878B (zh) * 2021-02-03 2022-12-02 北京智仁美博生物科技有限公司 针对人tslp的多种抗体及其用途
CN114853888B (zh) * 2021-02-05 2023-11-03 上海洛启生物医药技术有限公司 抗tslp纳米抗体及其应用
EP4302778A4 (en) * 2021-03-03 2025-03-12 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-TSLP ANTIBODY
PH12023552762A1 (en) * 2021-04-19 2024-04-15 Medimmune Ltd An anti-tslp fab with improved stability
KR20230175245A (ko) 2021-04-23 2023-12-29 암젠 인크 변형된 항-tslp 항체
EP4326766A1 (en) * 2021-04-23 2024-02-28 Amgen Inc. Anti-tslp antibody compositions and uses thereof
CN113683694B (zh) * 2021-09-03 2022-05-13 江苏荃信生物医药股份有限公司 一种抗人tslp单克隆抗体及其应用
CN117209603B (zh) * 2021-12-02 2024-02-27 北京东方百泰生物科技股份有限公司 一种抗tslp的单克隆抗体、其抗原结合片段及其应用
CN117327176A (zh) * 2022-06-24 2024-01-02 南京融捷康生物科技有限公司 一种抗tslp的单域抗体及其用途
US12110324B2 (en) 2022-07-22 2024-10-08 Flagship Pioneering Innovations Vi, Llc Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
TW202426485A (zh) 2022-10-26 2024-07-01 美商安進公司 抗ｔｓｌｐ抗體組成物及其用途
WO2025049343A1 (en) * 2023-08-25 2025-03-06 Proteologix Us Inc. Anti-tslp antibody constructs and uses thereof
AU2024334289A1 (en) 2023-08-25 2026-04-09 Proteologix Us Inc. Anti-il-13 multispecific antibody constructs and uses thereof
CN117551195B (zh) * 2024-01-12 2024-04-09 杭州畅溪制药有限公司 靶向tslp的vhh纳米抗体及其应用
WO2025179220A1 (en) * 2024-02-22 2025-08-28 Flagship Pioneering Innovations Vi, Llc Dosing of antigen binding molecules targeting thymic stromal lymphopoietin (tslp)
WO2025264860A2 (en) 2024-06-18 2025-12-26 Yale University Methods of treating post-covid airway disease
US20260098100A1 (en) * 2024-10-04 2026-04-09 Prana Therapies, Inc. Il-4r and tslp inhibitors and methods of use thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DE69120146T2 (de) 1990-01-12 1996-12-12 Cell Genesys Inc Erzeugung xenogener antikörper
WO1996033735A1 (en) 1995-04-27 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
US7982016B2 (en) * 2007-09-10 2011-07-19 Amgen Inc. Antigen binding proteins capable of binding thymic stromal lymphopoietin
US8359965B2 (en) 2007-09-17 2013-01-29 Oxford J Craig Apparatus and method for broad spectrum radiation attenuation
UY32038A (es) 2008-08-08 2010-03-26 Glaxo Wellcome Mfg Pte Ltd Inmunoblobulinas anti-cd127 y sus usos
ES2784123T3 (es) 2009-11-04 2020-09-22 Merck Sharp & Dohme Anticuerpo anti TSLP genomodificado
WO2012007495A1 (en) 2010-07-15 2012-01-19 F. Hoffmann-La Roche Ag Antibodies specifically binding to human tslpr and methods of use
US9100245B1 (en) 2012-02-08 2015-08-04 Amazon Technologies, Inc. Identifying protected media files
US9306926B2 (en) 2013-03-15 2016-04-05 Brian A. Truong User authentication using unique hidden identifiers
AR098155A1 (es) * 2013-10-23 2016-05-04 Genentech Inc Métodos para diagnosticar y tratar trastornos eosinofílicos
CA2955086A1 (en) * 2014-08-08 2016-02-11 Alector Llc Anti-trem2 antibodies and methods of use thereof
KR20170123315A (ko) * 2015-03-11 2017-11-07 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Tslp 결합 단백질
EA038332B1 (ru) 2015-09-09 2021-08-10 Новартис Аг Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул
KR102666879B1 (ko) * 2017-04-12 2024-05-23 암젠 인크 항-tslp 항체를 이용한 천식의 치료

Similar Documents

Publication Publication Date Title
JP2024150751A5 (https=)
JP7766392B2 (ja) 治療用抗ｃｄ４０リガンド抗体
JP2022105178A (ja) 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染症を治療および予防するための組成物および方法
JP2018183173A5 (https=)
JP2022524588A5 (https=)
JP6513657B2 (ja) Ｉｌ−１７ａ結合剤およびその用途
JP2021526534A5 (https=)
JP2020509756A5 (https=)
JP2008502366A5 (https=)
JP2022549172A5 (https=)
JP2018519364A5 (https=)
JP2013056885A5 (https=)
JP2019527194A5 (https=)
ME02371B (me) Sastojci i postupci za dijagnstikovanje i tretman raka
US20240209082A1 (en) Anti-cd96 antibodies and methods of use thereof
RU2019140602A (ru) АНТИ-GARP-TGF-β-АНТИТЕЛА
JP2024516595A5 (https=)
JP2022545741A5 (https=)
JP2018522540A5 (https=)
JP2024541680A5 (https=)
JP2021534797A5 (https=)
JP2023519962A5 (https=)
JP2020527152A5 (https=)
JP2013508292A5 (https=)
JP2023506465A5 (https=)